Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Tandem C2 domains, nuclear pseudogene" (ENSG00000232889) is classified as a pseudogene, specifically a non-coding sequence with similarity to the protein-coding TC2N (tandem C2 domains, nuclear) locus, but it does not encode a functional protein. Pseudogenes such as this one are not transcribed or translated into functional proteins and are generally considered biologically inactive. They are not considered therapeutic targets in drug discovery and have no reported roles in coding for proteins, involvement in biological functions, or disease processes[1][5]. If structured, this entry should be clearly flagged as a pseudogene and not an actionable therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tandem C2 domains, nuclear pseudogene (TC2N pseudogene).